Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel

Objective: Focal epilepsy is the most common subtype of epilepsies in which the influence of underlying genetic factors is emerging but remains largely uncharacterized. The purpose of this study is to determine the contribution of currently known disease-causing genes in a large cohort (n = 593) of...

Full description

Bibliographic Details
Main Authors: Tsai, Meng Han, Chan, Chung Kin, Chang, Ying Chao, Lin, Chih Hsiang, Liou, Chia Wei, Chang, Wen Neng, Ng, Ching Ching, Lim, Kheng Seang, Hwang, Daw Yang
Format: Article
Published: Frontiers Media 2018
Subjects:
_version_ 1825721500664070144
author Tsai, Meng Han
Chan, Chung Kin
Chang, Ying Chao
Lin, Chih Hsiang
Liou, Chia Wei
Chang, Wen Neng
Ng, Ching Ching
Lim, Kheng Seang
Hwang, Daw Yang
author_facet Tsai, Meng Han
Chan, Chung Kin
Chang, Ying Chao
Lin, Chih Hsiang
Liou, Chia Wei
Chang, Wen Neng
Ng, Ching Ching
Lim, Kheng Seang
Hwang, Daw Yang
author_sort Tsai, Meng Han
collection UM
description Objective: Focal epilepsy is the most common subtype of epilepsies in which the influence of underlying genetic factors is emerging but remains largely uncharacterized. The purpose of this study is to determine the contribution of currently known disease-causing genes in a large cohort (n = 593) of common focal non-lesional epilepsy patients. Methods: The customized focal epilepsy gene panel (21 genes) was based on multiplex polymerase chain reaction (PCR) and sequenced by Illumina MiSeq platform. Results: Eleven variants (1.85%) were considered as pathogenic or likely pathogenic, including seven novel mutations. There were three SCN1A (p.Leu890Pro, p.Arg1636Ter, and p.Met1714Val), three PRRT2 (two p.Arg217Profs*8 and p.Leu298Pro), two CHRNA4 (p.Ser284Leu, p.Ile321Asn), one DEPDC5 (p.Val516Ter), one PCDH19 (p.Asp233Asn), and one SLC2A1 (p.Ser414Ter) variants. Additionally, 16 other rare variants were classified as unknown significance due to inconsistent phenotype or lack of segregation data. Conclusion: Currently known focal epilepsy genes only explained a very small subset of focal epilepsy patients. This indicates that the underlying genetic architecture of focal epilepsies is very heterogeneous and more novel genes are likely to be discovered. Our study highlights the usefulness, challenges and limitations of using the multi-gene panel as a diagnostic test in routine clinical practice in patients with focal epilepsy.
first_indexed 2024-03-06T05:51:15Z
format Article
id um.eprints-20454
institution Universiti Malaya
last_indexed 2024-03-06T05:51:15Z
publishDate 2018
publisher Frontiers Media
record_format dspace
spelling um.eprints-204542019-02-22T08:51:10Z http://eprints.um.edu.my/20454/ Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel Tsai, Meng Han Chan, Chung Kin Chang, Ying Chao Lin, Chih Hsiang Liou, Chia Wei Chang, Wen Neng Ng, Ching Ching Lim, Kheng Seang Hwang, Daw Yang Q Science (General) QH Natural history R Medicine Objective: Focal epilepsy is the most common subtype of epilepsies in which the influence of underlying genetic factors is emerging but remains largely uncharacterized. The purpose of this study is to determine the contribution of currently known disease-causing genes in a large cohort (n = 593) of common focal non-lesional epilepsy patients. Methods: The customized focal epilepsy gene panel (21 genes) was based on multiplex polymerase chain reaction (PCR) and sequenced by Illumina MiSeq platform. Results: Eleven variants (1.85%) were considered as pathogenic or likely pathogenic, including seven novel mutations. There were three SCN1A (p.Leu890Pro, p.Arg1636Ter, and p.Met1714Val), three PRRT2 (two p.Arg217Profs*8 and p.Leu298Pro), two CHRNA4 (p.Ser284Leu, p.Ile321Asn), one DEPDC5 (p.Val516Ter), one PCDH19 (p.Asp233Asn), and one SLC2A1 (p.Ser414Ter) variants. Additionally, 16 other rare variants were classified as unknown significance due to inconsistent phenotype or lack of segregation data. Conclusion: Currently known focal epilepsy genes only explained a very small subset of focal epilepsy patients. This indicates that the underlying genetic architecture of focal epilepsies is very heterogeneous and more novel genes are likely to be discovered. Our study highlights the usefulness, challenges and limitations of using the multi-gene panel as a diagnostic test in routine clinical practice in patients with focal epilepsy. Frontiers Media 2018 Article PeerReviewed Tsai, Meng Han and Chan, Chung Kin and Chang, Ying Chao and Lin, Chih Hsiang and Liou, Chia Wei and Chang, Wen Neng and Ng, Ching Ching and Lim, Kheng Seang and Hwang, Daw Yang (2018) Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel. Frontiers in Neurology, 9. p. 515. ISSN 1664-2295, DOI https://doi.org/10.3389/fneur.2018.00515 <https://doi.org/10.3389/fneur.2018.00515>. https://doi.org/10.3389/fneur.2018.00515 doi:10.3389/fneur.2018.00515
spellingShingle Q Science (General)
QH Natural history
R Medicine
Tsai, Meng Han
Chan, Chung Kin
Chang, Ying Chao
Lin, Chih Hsiang
Liou, Chia Wei
Chang, Wen Neng
Ng, Ching Ching
Lim, Kheng Seang
Hwang, Daw Yang
Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel
title Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel
title_full Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel
title_fullStr Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel
title_full_unstemmed Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel
title_short Molecular Genetic Characterization of Patients With Focal Epilepsy Using a Customized Targeted Resequencing Gene Panel
title_sort molecular genetic characterization of patients with focal epilepsy using a customized targeted resequencing gene panel
topic Q Science (General)
QH Natural history
R Medicine
work_keys_str_mv AT tsaimenghan moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT chanchungkin moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT changyingchao moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT linchihhsiang moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT liouchiawei moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT changwenneng moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT ngchingching moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT limkhengseang moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel
AT hwangdawyang moleculargeneticcharacterizationofpatientswithfocalepilepsyusingacustomizedtargetedresequencinggenepanel